Ribbon Bio Appoints Jay Therrien as Chief Business Officer
Vienna, Sept. 8, 2026 – Ribbon Bio, a leader in cell-free DNA assembly, has appointed Jay Therrien as Chief Business Officer. Therrien will focus on the company’s commercial strategy and growth initiatives within its executive leadership team.
Bringing over two decades of experience in the life sciences and genomics sectors, Therrien previously served as Chief Commercial Officer at Ultima Genomics and held executive roles at various industry leaders like Illumina and Life Technologies. He has been instrumental in launching breakthrough technologies in genomic applications.
As Chief Business Officer, Therrien will spearhead efforts to expand the adoption of Ribbon Bio’s cell-free DNA solutions, particularly the new MiroMine™ kit, which allows users to leverage the company’s advanced assembly algorithms directly in their labs.
Therrien expressed enthusiasm for joining Ribbon Bio, emphasizing the company’s potential to transform DNA synthesis and meet growing market demands without requiring specialized equipment.
Jodi Barrientos, CEO of Ribbon Bio, welcomed Therrien, citing his extensive experience as crucial for the company’s growth and vision.
About Ribbon Bio
Ribbon Bio specializes in cell-free DNA assembly, providing researchers with high-fidelity DNA molecules independent of traditional bacterial processes. This approach offers advantages like faster production timelines and greater reliability, enabling flexibility and efficiency in genomic research. For more information, visit www.ribbonbio.com.
For original content and multimedia, visit: PR Newswire.
